Methotrexate in combination with tumor necrosis factor (TNF) inhibitors induces high remission rates in rheumatoid arthritis patients53 or higher drug survival in psoriatic arthrosis patients54. The gene discussed is TNF; the disease is rheumatoid arthritis.